loading

Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스

pulisher
Apr 03, 2025

Capnia Inc stock soars to 52-week high, hits $74 mark - Investing.com

Apr 03, 2025
pulisher
Apr 02, 2025

Soleno therapeutics SVP sells $265,156 in stock - Investing.com

Apr 02, 2025
pulisher
Apr 01, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 699,095 Shares - MarketBeat

Apr 01, 2025
pulisher
Apr 01, 2025

Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

High Growth Tech Stocks To Watch In The US April 2025 - simplywall.st

Apr 01, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO sells $35.3 million in stock By Investing.com - Investing.com Philippines

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics exec sells shares worth $9.5 million By Investing.com - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics director Matthew Pauls sells $424,797 in stock By Investing.com - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CCO sells shares worth $2.48m By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics Executives and Director Sell Shares - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CFO sells $4.88 million in stock By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics Executives Sell Shares - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno stock price target raised to $100 at H.C. Wainwright By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno stock price target raised to $100 at H.C. Wainwright - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Mid Cap Stocks To ResearchMarch 27th - MarketBeat

Mar 31, 2025
pulisher
Mar 30, 2025

Soleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS Treatment - Markets Insider

Mar 30, 2025
pulisher
Mar 29, 2025

Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week? - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

10 Stocks Outperform Broader Market Last Week - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Soleno Therapeutics (NASDAQ:SLNO) Trading 3.9% Higher on Analyst Upgrade - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN

Mar 29, 2025
pulisher
Mar 29, 2025

Vivo opportunity sells $124 million in Soleno Therapeutics stock By Investing.com - Investing.com South Africa

Mar 29, 2025
pulisher
Mar 29, 2025

Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday? - MSN

Mar 29, 2025
pulisher
Mar 29, 2025

Vivo opportunity sells $124 million in Soleno Therapeutics stock - Investing.com Australia

Mar 29, 2025
pulisher
Mar 29, 2025

Guggenheim raises Soleno Therapeutics stock target to $81 By Investing.com - Investing.com Canada

Mar 29, 2025
pulisher
Mar 28, 2025

Major Shareholder Sells Massive Stake in Soleno Therapeutics! - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Stifel raises Soleno stock target to $108 after FDA approval By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

PANTHERx® Rare Selected by Soleno Therapeutics for the Distribution of VYKAT™ XR - PR Newswire

Mar 28, 2025
pulisher
Mar 28, 2025

Stifel raises Soleno stock target to $108 after FDA approval - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Soleno Therapeutics price target raised to $108 from $74 at Stifel - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Guggenheim raises Soleno Therapeutics stock target to $81 - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

FDA Approves First Therapy To Treat Hyperphagia in Prader-Willi Syndrome - Technology Networks

Mar 28, 2025
pulisher
Mar 28, 2025

Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday? - Insider Monkey

Mar 28, 2025
pulisher
Mar 28, 2025

Soleno Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90 - Investor's Business Daily

Mar 28, 2025
pulisher
Mar 28, 2025

FDA Greenlights Soleno Therapeutics’ VYKAT XR for PWS Hyperphagia - geneonline.com

Mar 28, 2025
pulisher
Mar 27, 2025

Oppenheimer lifts Soleno Therapeutics stock target to $105 By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease - Mugglehead

Mar 27, 2025
pulisher
Mar 27, 2025

Biotech Zooms Into Breakout Zone On Hard-Fought Approval - Investor's Business Daily

Mar 27, 2025
pulisher
Mar 27, 2025

First Prader-Willi treatment Vykat XR FDA-approved: Soleno soars - BioWorld MedTech

Mar 27, 2025
pulisher
Mar 27, 2025

Tiny Drugmaker Soars on FDA Win to Treat Never-Ending Hunger - Bloomberg

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics: In No Rush To Join Buying Frenzy Despite Vykat Approval (SLNO) - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno wins FDA approval for Prader-Willi hyperphagia treatment - Yahoo

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Shares Are Up Today: What's Going On? - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

FDA Approves Soleno Therapeutics’ Vykat XR for Hyperphagia in Patients with Prader-Willi Syndrome - Pharmaceutical Executive

Mar 27, 2025
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):